Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
July 21, 2007
Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach
Mark R Berry, Michael D Likar
Journal of Pharmaceutical and Biomedical Analysis
|
June 25, 2005
Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride
Michael D Likar, Hany L Mansour, Jeffrey W Harwood
Journal of Pharmaceutical and Biomedical Analysis
|
March 25, 2011
Rapid identification and absence of drug tests for AG-013736 in 1mg Axitinib tablets by ion mobility spectrometry and DART™ mass spectrometry
Michael D Likar, Guilong Cheng, Nidhi Mahajan, et al.
Profiles of Drug Substances, Excipients, and Related Methodology
|
April 4, 2012
Sertraline (L)-lactate: comprehensive profile
Michael D Likar, Jon Bordner, Diane M Rescek, et al.
The AAPS Journal
|
November 6, 2015
Erratum to: Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
Dorys Argelia Diaz, Stephen T Colgan, Connie S Langer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 15, 2011
Osmotic capsules: A universal oral, controlled-release drug delivery dosage form
Kenneth C Waterman, G Scott Goeken, Sanjay Konagurthu, et al.
The AAPS Journal
|
October 3, 2015
Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
Dorys Argelia Diaz, Stephen T Colgan, Connie S Langer, et al.
Journal of Pharmaceutical Sciences
|
August 27, 2018
Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component
Michael D Likar, Sophia C Carroll, Stephen T Colgan, et al.
Journal of Pharmaceutical Sciences
|
June 6, 2016
Use of Activated Carbon in Packaging to Attenuate Formaldehyde-Induced and Formic Acid-Induced Degradation and Reduce Gelatin Cross-Linking in Solid Dosage Forms
Stephen T Colgan, Todd C Zelesky, Raymond Chen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Pharmaceutical and Biomedical Analysis
|
July 21, 2007
Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach
Mark R Berry, Michael D Likar
Journal of Pharmaceutical and Biomedical Analysis
|
June 25, 2005
Development and validation of a dissolution test for a once-a-day combination tablet of immediate-release cetirizine dihydrochloride and extended-release pseudoephedrine hydrochloride
Michael D Likar, Hany L Mansour, Jeffrey W Harwood
Journal of Pharmaceutical and Biomedical Analysis
|
March 25, 2011
Rapid identification and absence of drug tests for AG-013736 in 1mg Axitinib tablets by ion mobility spectrometry and DART™ mass spectrometry
Michael D Likar, Guilong Cheng, Nidhi Mahajan, et al.
Profiles of Drug Substances, Excipients, and Related Methodology
|
April 4, 2012
Sertraline (L)-lactate: comprehensive profile
Michael D Likar, Jon Bordner, Diane M Rescek, et al.
The AAPS Journal
|
November 6, 2015
Erratum to: Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
Dorys Argelia Diaz, Stephen T Colgan, Connie S Langer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 15, 2011
Osmotic capsules: A universal oral, controlled-release drug delivery dosage form
Kenneth C Waterman, G Scott Goeken, Sanjay Konagurthu, et al.
The AAPS Journal
|
October 3, 2015
Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
Dorys Argelia Diaz, Stephen T Colgan, Connie S Langer, et al.
Journal of Pharmaceutical Sciences
|
August 27, 2018
Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component
Michael D Likar, Sophia C Carroll, Stephen T Colgan, et al.
Journal of Pharmaceutical Sciences
|
June 6, 2016
Use of Activated Carbon in Packaging to Attenuate Formaldehyde-Induced and Formic Acid-Induced Degradation and Reduce Gelatin Cross-Linking in Solid Dosage Forms
Stephen T Colgan, Todd C Zelesky, Raymond Chen, et al.
Page
of 1